Brief: Portage Biotech Reports Promising Preclinical Results In Mesothelioma Supporting First-In-Human Trial Of Port-7
27/03/2025 20:46
March 27 (Reuters) - Portage Biotech Inc PRTG.O: PORTAGE BIOTECH REPORTS PROMISING PRECLINICAL RESULTS IN MESOTHELIOMA SUPPORTING FIRST-IN-HUMAN TRIAL OF PORT-7 Source text: ID:nGNX1x9XGg Further company coverage: PRTG.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alpha Compute
See all newsAlpha Compute Corp expected to post a loss of $3.50 a share - Earnings Preview
NASDAQ RESUMED AT 10:18 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:13 AM
Brief: Alpha Compute Signs Binding Gpu Contract, Leasing ALPHA-03 Cluster Under Four-Year, $81.7 Million Agreement In Its Missouri Superintelligence Factory
Alpha Compute Corp expected to post a loss of $3.50 a share - Earnings Preview